SCHEMBL6025692

SCHEMBL6025692

O=C1c2ccccc2Cc2ncccc21

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOA P21397 2/20 0.61
▸ CES1 P23141 3/20 0.52
▸ BCHE P06276 1/20 0.52
▸ GAA P10253 1/20 0.48
▸ CYP19A1 P11511 2/20 0.45
▸ TNF P01375 2/20 0.45
▸ MAPK14 Q16539 1/20 0.45
▸ ALDH1A1 P00352 3/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ PTPRC P08575 2/20 0.44
▸ CTSL P07711 1/20 0.44
▸ CTSS P25774 1/20 0.44
▸ PTPN13 Q12923 1/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ TDP2 O95551 1/20 0.44
▸ NSD2 O96028 1/20 0.44
▸ ABL1 P00519 1/20 0.44
▸ PLCG1 P19174 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29360004 0.84 METAP2 (0.46) MAOACES1BCHEALDH1A1CYP1A2
SCHEMBL27174135 0.84 METAP2 (0.46) MAOACES1BCHEALDH1A1CYP1A2
SCHEMBL30011414 0.84 METAP2 (0.46) MAOACES1BCHEALDH1A1CYP1A2
SCHEMBL51294 0.84 METAP2 (0.46) MAOACES1BCHEALDH1A1CYP1A2
SCHEMBL6385750 0.84 CES1 (0.59) MAOACES1GAACYP19A1MAPK14
SCHEMBL10258112 0.78 METAP2 (0.41) MAOACES1BCHECYP1A2CYP2C19
SCHEMBL30701140 0.78 MAOA (0.61) MAOACES1BCHEGAACYP19A1
Anthrone SCHEMBL27274516 0.77 MAOA (0.60) MAOACES1BCHEGAACYP19A1
Anthrone SCHEMBL18143 0.77 MAOA (1.00) MAOACES1BCHECYP19A1TNF
Anthrone SCHEMBL29357010 0.77 MAOA (1.00) MAOACES1BCHECYP19A1TNF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001017997-A1 SUBSTITUTED DIAZAANTHRACENE COMPOUNDS HAVING PHARMACEUTICAL UTILITY DIAZANS LIMITED (CA) 2001-03-15 — — WO claimed
US-9905886-B2 Non-aqueous liquid electrolyte for secondary battery and secondary battery FUJIFILM CORPORATION (JP) 2018-02-27 — — US disclosed
US-9905886-B2 Non-aqueous liquid electrolyte for secondary battery and secondary battery FUJIFILM CORPORATION (JP) 2018-02-27 — — US disclosed
US-20140377666-A1 NON-AQUEOUS LIQUID ELECTROLYTE FOR SECONDARY BATTERY AND SECONDARY BATTERY FUJIFILM CORPORATION (JP) 2014-12-25 — — US disclosed
US-20140377666-A1 NON-AQUEOUS LIQUID ELECTROLYTE FOR SECONDARY BATTERY AND SECONDARY BATTERY FUJIFILM CORPORATION (JP) 2014-12-25 — — US disclosed
EP-1723116-A2 TETRAHYDROQUINOLINONES AND THEIR USE AS ANTAGONISTS OF METABOTROPIC GLUTAMATE RECEPTORS Merz Pharma GmbH & Co. KGaA (DE) 2006-11-22 — — EP disclosed
WO-2005082856-A2 TETRAHYDROQUINOLINONES AND THEIR USE AS ANTAGONISTS OF METABOTROPIC GLUTAMATE RECEPTORS MERZ PHARMA GMBH & CO. KGAA (DE) 2005-09-09 — — WO disclosed
WO-2001017997-A1 SUBSTITUTED DIAZAANTHRACENE COMPOUNDS HAVING PHARMACEUTICAL UTILITY DIAZANS LIMITED (CA) 2001-03-15 — — WO disclosed
Send feedback